Annual SG&A
$14.22 M
-$13.09 M-47.94%
31 December 2023
Summary:
NRx Pharmaceuticals annual selling, general & administrative expenses is currently $14.22 million, with the most recent change of -$13.09 million (-47.94%) on 31 December 2023. During the last 3 years, it has risen by +$2.78 million (+24.31%). NRXPW annual SG&A is now -81.03% below its all-time high of $74.94 million, reached on 31 December 2021.NRXPW Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.41 M
-$1.83 M-43.22%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly selling, general & administrative expenses is currently $2.41 million, with the most recent change of -$1.83 million (-43.22%) on 30 September 2024. Over the past year, it has dropped by -$83.00 thousand (-3.33%). NRXPW quarterly SG&A is now -95.05% below its all-time high of $48.66 million, reached on 31 December 2021.NRXPW Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.05 B
-$20.38 M-1.98%
30 September 2024
Summary:
NRx Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.05 billion, with the most recent change of -$20.38 million (-1.98%) on 30 September 2024. Over the past year, it has dropped by -$1.05 billion (-42184.56%). NRXPW TTM SG&A is now -55643.42% below its all-time high of $85.17 million, reached on 31 March 2022.NRXPW TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.9% | -3.3% | -10000.0% |
| 3 y3 years | +24.3% | -82.6% | -3798.1% |
| 5 y5 years | - | - | - |
NRXPW Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.0% | +24.3% | -95.0% | +28.8% | -321.8% | at low |
| 5 y | 5 years | -81.0% | -95.0% | <-9999.0% | at low | ||
| alltime | all time | -81.0% | -95.0% | <-9999.0% | at low |
NRx Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.41 M(-43.2%) | $12.78 M(-0.6%) |
| June 2024 | - | $4.25 M(-0.1%) | $12.86 M(+49.3%) |
| Mar 2024 | - | $4.25 M(+127.0%) | $8.62 M(+97.3%) |
| Dec 2023 | $14.22 M(-47.9%) | $1.87 M(-24.9%) | $4.37 M(+75.1%) |
| Sept 2023 | - | $2.49 M(-62.5%) | $2.49 M(-96.9%) |
| Dec 2022 | $27.31 M | - | - |
| June 2022 | - | $6.64 M(-35.0%) | $79.35 M(-6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $10.22 M(-79.0%) | $85.17 M(+10.5%) |
| Dec 2021 | $74.94 M(+555.3%) | $48.66 M(+252.0%) | $77.05 M(+171.5%) |
| Sept 2021 | - | $13.82 M(+11.0%) | $28.38 M(+94.9%) |
| June 2021 | - | $12.46 M(+492.9%) | $14.56 M(+592.9%) |
| Mar 2021 | - | $2.10 M(>+9900.0%) | $2.10 M(>+9900.0%) |
| Dec 2020 | $11.44 M(>+9900.0%) | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is NRx Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual SG&A year-on-year change?
- What is NRx Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly SG&A year-on-year change?
- What is NRx Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM SG&A year-on-year change?
What is NRx Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of NRXPW is $14.22 M
What is the all time high annual SG&A for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual selling, general & administrative expenses is $74.94 M
What is NRx Pharmaceuticals annual SG&A year-on-year change?
Over the past year, NRXPW annual selling, general & administrative expenses has changed by -$13.09 M (-47.94%)
What is NRx Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of NRXPW is $2.41 M
What is the all time high quarterly SG&A for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $48.66 M
What is NRx Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, NRXPW quarterly selling, general & administrative expenses has changed by -$83.00 K (-3.33%)
What is NRx Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of NRXPW is -$1.05 B
What is the all time high TTM SG&A for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM selling, general & administrative expenses is $85.17 M
What is NRx Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, NRXPW TTM selling, general & administrative expenses has changed by -$1.05 B (-42184.56%)